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Oreochromis niloticusAbstract The present study was undertaken to evaluate the therapeutic efficacy of reduced glu-
tathione (GSH) and its curative prospective for the alleviation of aflatoxicosis in Oreochromis niloti-
cus. 180 apparently healthy O. niloticus were assigned to six groups (A–F); A and B were kept as a
negative and positive control of AFB1. Fish in groups C and D were injected with GSH at 3 and
6 mg/kg body weight, BW, respectively), while those in groups E and F were injected at the start
of the experiment by AFB1 (6 mg/kg BW) then at the 7th day, they were injected with GSH at
two doses. The results showed that AFB1 has a significant potency for increasing plasma creatinine
and uric acid and for reducing the values of plasma urea and hepatic antioxidants. In addition,
AFB1 reflected an up-regulation in the expression of the hepatic gene of glutathione peroxidase
(GPx) and cytochrome CYP1A. The therapeutic efficacy of GSH against aflatoxicosis was recorded
at the low level of GSH that improved values of both uric acid and hepatic antioxidants. In addition
to that, GSH reflected up-regulated and down-regulated GPx and CYP1A gene expressions, respec-
tively in fish group E, which gave a splendid indicator of the positive ability of GSH in the detox-
ification of aflatoxin in O. niloticus, while the optimal level of GSH antioxidant for detoxification of
aflatoxin effects may need more studies.
 2015 National Institute of Oceanography and Fisheries. Hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Aflatoxins are chemicals created by a few types of pathogenic
fungi (Aspergillus flavus and Aspergillus parasiticus) generally
known as molds. Aflatoxin B1 is a standout among the mosttoxic mycotoxin in the world; it has negative effects on fish
production and economic profits in aquaculture (Jantrarotai
et al., 1990). Aflatoxin metabolites induce aflatoxicosis disease
that can influence numerous species of fish (Santacroce et al.,
2008). Liver is the most affected organ by aflatoxicosis and
is associated with biotransformation and detoxification pro-
cesses. At first, AFB1 is metabolically biotransformed by the
cytochrome P450 group of enzymes (phase I) to a reactive inter-
mediate metabolite, AFB1–8, 9-epoxide (AFBO), (Gallagher
Table 1 Experimental design.
Group 0 Day 7th Day
A 25% DMSO S.W.
B AFB1 (6 mg/kg B.W.) S.W.
C GSH (3 mg/kg B.W.) 25% DMSO
D GSH (6 mg/kg B.W.) 25% DMSO
E AFB1 (6 mg/kg B.W.) GSH (3 mg/kg B.W.)
F AFB1 (6 mg/kg B.W.) GSH (6 mg/kg B.W.)
S.W. = saline water.
338 M.I. El-Barbaryet al., 1996) which interacts with cellular macromolecules (pro-
tein, lipid, DNA) to induce oxidative damage in cells and
DNA leading to toxicity and carcinogenicity (Eaton and
Groopman, 1994; Yang et al., 2000). Thus, the sensitivity of
fish to the hepatocarcinogen can often be clarified by varia-
tions in the biotransformation of AFB1 (Eaton and
Gallagher, 1994; Bailey et al., 1998).
AFB1 toxicity shows clinical signs including loss of body
weight, increased disease susceptibility, liver dysfunction and
increased mortality (Murjani, 2003; Santacroce et al., 2008).
Moreover, the detoxification of AFBO occurs through the
biotransformation enzymes, also in the liver (Manson
et al., 1997). The pathway of biotransformation is mediated
by phase I enzymes, such as cytochrome P450 (CYP) which
plays a vital role in phase-I metabolism of many drugs or
toxins and phase II (conjugation) as well, or sometimes even
a combination of both (Brandon et al., 2003). Phase I reac-
tions facilitate bioactivation (Sumit and Roger, 2010)
whereas phase II biotransformation reactions have resulted
in detoxification and excretion. Most fish have a second
group of biotransformation enzymes that are referred to as
conjugation antioxidant defenses, such as glutathione
(Clark et al., 1991). Such a conjugation has shown that it
protects against the hepatocarcinogenic effects of AFB1
(Lotlikar et al., 1984) where the resulting conjugate is often
less toxic than the parent compound. AFB1–glutathione con-
jugation is a key (segment) component of antioxidant defense
mechanisms and the major detoxification pathway of afla-
toxin metabolites (Sayeed et al., 2003; Shi et al., 2004). Liver
is the major site of synthesis of glutathione, although it is
synthesized in every cell of the body (Wu et al., 2004;
Mori et al., 1992).
Some chemopreventions have been evaluated in fish for
reducing aflatoxicosis. The protective and adaptive role of
glutathione against toxicity is well settled in aquatic animals
(Otto and Moon, 1995; Regoli and Principato, 1995;
El-Barbary, 2010) because it has a fundamental role in many
biochemical and pharmacological reactions (Locigno and
Castronovo, 2001; Paolicchi et al., 2002). Also, it is a stand-
out among the most critical factors that protect from oxida-
tive attacks in light of the fact that it acts as a reducing agent
and free-radical trapper; it is also known to be a co-factor
substrate and/or glutathione-related enzymes (Verma et al.,
2007).
In addition to that, the potency of glutathione that was
injected (3 mg/kg BW) to overcome the side effects of AFB1
on liver histology, hepatosomatic index, lipid peroxidation,
total antioxidant capacity and liver function of O. niloticus
aflatoxicosis was investigated in a complementary study (El-
Barbary and Mohamed, 2014).
Therefore, the aim of this study is to explore the
impacts of AFB1 on the activities of hepatic antioxidants,
kidney function and the gene expression of some of detox-
ified enzymes (CYP1A and GPx) in fish. Moreover, another
aim of this study is to evaluate the therapeutic efficacy of
glutathione (GSH) and its curative prospective against the
adverse effects of AFB on antioxidants and gene expression
of both GPx enzyme and cytochrome (CYP1A) in O. niloti-
cus. The target of using glutathione in this study is to stim-
ulate antioxidants and/or inhibit CYPA1 because studying
their gene expression is considered critical in this
evaluation.Materials and methods
Preparation of aflatoxin B1
Aflatoxin B1 was produced in a liquid medium by Aspergillus
parasiticus (NRRL 2999) as indicated by the technique of
Ready et al. (1971). AFB1 was quantitatively assessed by thin
layer chromatography, TLC, (AOAC, 2000). Then AFB1 was
freshly dissolved in 25% DMSO (1:3 water) to the appropriate
concentration before injection.
Glutathione
Reduced GSH has been obtained from Sigma Chemical Co.
This antioxidant was dissolved in saline water as described in
the experimental design.
Experimental protocol
Before the initiation of the experiment, fish were acclimated to
the aquarium conditions for a week. One hundred and eighty
fish of Nile tilapia with a mean weight of 40 ± 0.2 g were
obtained from El-Serw Fish Research Station. Fish were ran-
domly divided into six groups, each group was stocked into
3 aquaria, and each aquarium (70  40  30 cm) contained
10 fish and was supplied with 40-L dechlorinated tap water
and aerated with a compressor and air stones. During the
experiment (2 weeks), the fish were fed twice daily at a feeding
rate of 3% of the actual body weight. Data in Table 1 reported
that, fish in-group A were injected intraperitoneally (IP) with
0.5 ml of 0.25% DMSO per fish as a control group.
Group B fish were injected IP with AFB1 6 mg/kg BW, (1/6
of the LC50, as a single dose at day zero of the experiment,
according to El-Barbary, 2008). Groups C and D were injected
IP with 3 and 6 mg/kg BW of GSH, respectively. In addition,
groups E and F were injected with AFB1 (6 mg/kg of AFB1)
7 days before the injection of GSH (3 and 6 mg/kg BW,
respectively).
Collection of samples for assessment of kidney function
The fish were sacrificed at the end of experiment (after
14 days). Blood was collected by cardiac puncture using anti-
coagulant (EDTA). The plasma was separated by centrifuga-
tion with 3000g for 15 min at 4 C and stored at 20 C
until further use. The activities of creatinine, urea and uric acid
were determined using commercial calorimetric kits (Stanbio
Laboratory Diagnostic, USA).
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The Glutathione content as a non-enzymatic antioxidant was
measured according to the method of Beutler et al. (1963)
and was expressed as mg per g of protein. The method used
metaphosphoric acid for protein precipitation and 5,5-
dithiobis (2-nitrobenzoic acid) (DTNB) for color development,
its density was measured at 412 nm. The activity of GPx was
estimated according to the method described by Paglia and
Valentine (1967). Catalase (CAT) activity was assayed follow-
ing the methods of Bergmeyer (1974). The activity of glu-
tathione reductase (GRx) was estimated by measuring the
reduction of oxidized glutathione to reduced glutathione in
liver tissues following the methods of Goldberg and Spooner
(1983) While protein were estimated using Folin–Lowry
method (Lowry et al., 1951).
Preparation of liver homogenate
Before the end of the experiment, six fish from each group (two
fish samples for each replicate) were sacrificed. Liver samples
were used for the determination of enzymatic and non-
enzymatic antioxidants.
Liver samples were homogenized using a Teflon Pestle con-
nected to a Braun homogenizer motor (25 strokes per minute
at 1000 rev/min) in an ice cold homogenate buffer (0.34 M
sucrose and 1 mM potassium dihydrogen phosphate, pH
7.0), the liver homogenate was diluted to yield a 5% (W/V)
liver homogenate. The homogenate was then centrifuged at
5000 rpm for 30 min at 4 C to precipitate insoluble materials.
The supernatant was used to assay enzymatic and non enzy-
matic antioxidants.
RNA isolation and cDNA synthesis
Total RNA was isolated from the liver tissues of homogenized
O. niloticus using The GeneJETTM RNA Purification
Kit (Thermo Scientific #K0731) and according to the
Chomczynski and Sacchi (1987) and Boom et al., (1990)
method. Total cDNA for real time PCR reactions were gener-
ated from 1 lg DNase treated total RNA from all samples
using RevertAid First Strand cDNA Synthesis Kit (Thermo
Scientific #K1621) as described by the manufacturer according
to Wiame et al. (2000).
Primer design and quantitative real time PCR
The expression levels of GPx and CYP1A genes were assessed
in control and treatment groups (A–C and E) by using quan-
titative real-time PCR. All PCR reactions were performed in
a Veriti 96-Well Thermal Cycler (Applied Biosystem Catalog
Number 4479071) which were performed using 10 ll of Max-
ima SYBR Green/ROX qPCR Master Mix (2x) (Thermo Sci-
entific #K0223) containing 25 mM MgCl2/1.5 mL, 0.25 ll of
both of diluted Forward and Reverse Primer (10 lM) with
2 ll of Template DNA and 7.5 ll water, nuclease-free to reach
the final volume of 20 ll at room temperature. PCR was car-
ried out using specifically designed primers according the real
time PCR requirements by the means of GEN runner software.
PCR master mix was prepared on ice with 10 ll of MaximaSYBR Green/ROX qPCR Master Mix (2x) (Thermo Scientific
#K0223) containing 25 mM MgCl2/1.5 mL, 0.25 ll of both of
diluted Forward and Reverse Primer (10 lM) with 2 ll of
Template DNA and 7.5 ll Water, nuclease-free for each
20 ll reaction to a tube at room temperature. The PCR reac-
tion mix was denatured at 95 C for 10 min before the first
PCR cycle. The thermal cycle profile was: (1) denaturation
for 15 s at 95 C, (2) annealing for 60 s at 60 C and (3) exten-
sion for 60 s at 60 C. 40 PCR cycles were used for the ampli-
fication of the samples. The primer sequences of the
housekeeping gene (b-actin) was used as an internal control
for normalization and GPx gene and their accession numbers
are shown in Table 2. For each treatment, the expressions of
GPx and CYP1A target gene were analyzed using Mx3000P
real-time PCR system (Stratagene, La Jolla, CA, USA).
Analytical methods
At the end of the experiment (either on the 14th or 21th day),
the obtained data were statistically analyzed by one-way anal-
ysis of variance using a software (SAS, 1996). When the F-test
was significant, least significant difference was calculated
according to the method of Duncan (1955) to compare the
means. The expressions of GPx and CYP1A genes were ana-
lyzed using the Comparative CT Method, also referred to as
the DDCT Method. The experimental values presented were
taken from User Bulletin #2, Relative Quantitation of Gene
Expression page 14.
Results
Assessment of kidney function
Aflatoxin B1 led to a low significant increase in plasma crea-
tinine and uric acid values (Figs. 1 and 2) in AFB1 injected
group B in comparison to control A, while AFB1 reflected a
decrease in the value of plasma urea (Fig. 3). Interestingly,
the usage of GSH antioxidant as a control positive showed
non-significantly altered creatinine with significantly altered
uric acid and urea levels after being compared with A. While
the usage of GSH after aflatoxicosis (E and F) did not have
a significant influence on creatinine and urea levels, uric acid
had improved when compared with the AFB1-injected group
(B).
Determination of antioxidant enzymes
Levels of hepatic enzymatic and non-enzymatic antioxidants
of control and experimental fish groups are shown in Table 3.
In group B, AFB1 led to a significant decrease in hepatic levels
of GSH, GPx, and GRx when compared to the control fish.
The low level of GSH (3 mg/kg BW) reflected non signifi-
cant changes in GSH and GRx activities in group C, while that
of GPx and CAT reflected a significant increase in their values
in comparison to the control group (A). Moreover, the high
level of GSH (6 mg/kg BW) reflected the highest activity of
GSH, GPx and CAT among the control groups (A–D). In
addition to that, the effect of low level of GSH reflected how
the values of antioxidants reverted back to near normal in
the control. The efficacy of GSH in ameliorating the negative
Table 2 Real-time PCR primers of O. niloticus GPx, CYP1A and b–actin genes.
Gene Accession number Gene Sequence (5-‘3’) Location Product size bp
GPx GQ853451.1 F-GGAACGACAACCAGGGACTA 177–196 160
R-TCCCTGGACGGACATACTTC 336–355
CYP1A FJ389918.2 F-GCAAATGGCTGCTGCTTGTCA 1912–1932 546
R-GTGTATCAAGGGTTCATGCCCT 2479–2458
b actin EU887951.1 F-GGGTCAGAAAGACAGCTACGGTT 42–63 143
R- CTCAGCTCGTTGTAGAAGGTGT 164–185
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Figure 1 Creatinine values in plasma of O. niloticus groups (A–
F) a–b: Different letters indicate significantly different mean
values among groups at (P< 0. 001).
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Figure 2 Uric acid values in plasma of O. niloticus groups (A–F)
a–b: Different letters indicate significantly different mean values
among groups at (P< 0. 001).
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Figure 3 Urea values in plasma of O. niloticus groups (A–F) a–
b: Different letters indicate significantly different mean values
among groups at (P< 0. 001).
340 M.I. El-Barbaryeffect of AFB1 in groups E and F, which were injected with
GSH at the two doses, reflected an improvement in the values
of all antioxidant enzymes and GSH in comparison to those of
the AFB1 group (B).
It was also found that in the E group, values of GPx, and
GSH reverted back to near normal while values of GRx and
CAT were significantly higher than those in the control fish
(group A) meaning that the low dose of GSH (3 mg/kg BW)
could be better than the high level.
Determination of CYP1A and GPx gene expressions in O.
niloticus livers
The gene expression of the two detoxified enzyme gene (GPx)
and CYPA1 enzyme gene was measured by real-time poly-
merase chain reaction (RT-PCR) in liver samples that werecollected at the end of the experiment (after 14-day) in groups
A, B, C, and E (Figs. 4 and 5) from O. niloticus. Because, the
results of both antioxidant enzyme values in this study and the
histology study along with the hepatosomatic index (HSI)
levels in the complementary study by El-Barbary and
Mohamed (2014), showed how the low concentration of
GSH (C and E) was better than the high level (D and F).
The results showed that the highest induction expression of
GPx mRNA was observed in the GSH group (C), followed
by that in the AFB1 group (B), while the E group had returned
to basal levels of expression in group A (Fig. 4). Concerning
CYPA1 gene (Fig. 5), groups B and C were significantly up
regulated when compared to control A. However, the CYPA1
mRNA expression in group E was significantly down
regulated.
Discussion
In a previous study, the detoxification of the aflatoxin B1 had
been evaluated as a strategy to decrease the AFB-associated
toxicity and detoxification potential by glutathione, as non-
enzymatic antioxidant, in O. niloticus; glutathione (3 mg/kg
BW injection IP) reduced the AFB1 associated lesion severity
in the liver with an increase in HSI levels. In addition, GSH
showed a clear trend in decreasing the negative effects of the
AFB1 on hepatic enzymes activity (ALT and AST) and total
protein in aflatoxicosis O. niloticus. However, GSH had signif-
icant potency for reducing the MDA (lipid peroxidation) val-
ues and increasing the values of total antioxidant capacity
(TAC) in the liver of O. niloticus that had been injected with
AFB1, (El-Barbary and Mohamed, 2014). In the present study,
the results of blood parameter findings might be considered as
Table 3 Effects of GSH and AFB1 on enzymatic and non-enzymatic antioxidants of O. niloticus.
Fish Groups GSH Mmole/mg tissue GPX U/mg tissue Glutathione reductase U/g tissue Catalase KU  106 mg/protein
A 0.16b ± 0.02 1.21b ± 0.01 3.56b ± 0.11 2.74e ± 0.16
B 0.04d ± 0.00 0.76c ± 0.05 1.95c ± 0.02 1.36e ± 0.02
C 0.18b ± 0.01 2.92a ± 0.01 3.12b ± 0.08 4.20c ± 1.30
D 1.17a ± 0.05 2.97a ± 0.01 1.69c ± 0.08 6.69b ± 0.01
E 0.17b ± 0.20 1.21b ± 0.01 4.70a ± 1.20 3.69d ± 0.16
F 0.08c ± 0.20 1.34b ± 0.01 3.90b ± 1.20 9.58a ± 0.70
Within each column, means superscript with different letters are (a–e) significantly different at (P< 0.001).
Figure 4 Alteration in the gene expression for GPx in the liver of
different O. niloticus groups (A–C and E), values are shown as
mean ± SE and asterisks indicate significant difference (P 6 0.05)
between fish groups.
Figure 5 Alteration in the gene expression for CYP1A in the
liver of different O. niloticus groups (A–C and E), values are
shown as mean ± SE and asterisks indicate significant difference
(P 6 0.05) between fish groups.
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AFB1-injection resulted in an increase in plasma creatinine and
uric acid in the aflatoxicosis group that revealed a marked
nephrotoxic effect of AFB1. This result agrees with many pre-
vious studies; Verma and Kolhe (1997) reported that the kid-
neys normally rapidly excrete creatinine, and that the
increased concentration in the serum indicated severe kidney
damage. Moreover El-Bahr et al. (2015) reported that the sig-
nificant appearance of creatinine in the serum of aflatoxin-fed
rats indicated the increased transformation of phosphocreatine
to creatinine in muscle that; might be due to lesser utilizationof phosphocreatine in muscular contraction. This result indi-
cates the diminished ability of the kidneys to filter these waste
products from the blood and excrete them in the urine. Also,
Bagherzadeh et al. (2012) and Ottinger and Kaattari (2000)
recorded that the biochemical changes during aflatoxicosis
could be because of the inhibition of protein synthesis in the
liver alongside other damages to the liver and kidney. Simi-
larly, the toxicity of AFB may be ascribed to the damage of
the hematopoietic tissue and the anterior kidney (Jantrarotai
and Lovell, 1990; Jantrarotai et al., 1990). These data indicated
a toxic effect of AFB1 on the liver, which was affirmed
histopathologically in the complementary study (El-Barbary
and Mohamed, 2014). In this study, the data showed a
decrease in values of plasma urea, which may be related to
the aflatoxin poisoning in the liver where the uric acid was con-
verted to urea. The uric acid is created by fish from exogenous
and endogenous purines, it is converted to urea in the liver and
to a less extent in the kidney, and excreted through the gills
(Stoskopf, 1993). So that, urea is the main end product of pro-
tein metabolism in the body, it is excreted in a small quantity
in relation to total nitrogen excretion. Stoskopf (1993) and
Borg et al. (1987) reported that blood urea could reflect the
state of protein metabolism and amino acid balance. So, deter-
mination of blood urea is used as an index of kidney function
(Melby, 1974).
Antioxidant defenses of fish are sensitive to ecological con-
tamination and can be used as biological markers of aquatic
ecological health (Sturve et al., 2008) including the effects of
AFB1. Aflatoxins can produce reactive oxygen species (ROS)
by either direct or indirect mechanisms (Halliwell, 1996)
induced the enzyme activity that is one of the significant prob-
lems for animal health. Since, the antioxidant defense system
can preclude the formation of ROS. The mechanism of antiox-
idant defenses is known, where GSH, a non-enzymic antioxi-
dant, (Wilhelm, 1996) plays a splendid task in defending the
cells from oxidative stress (Aldrige, 1981), which acts as a sub-
strate for GPx and GST enzymes that are included in different
ROS detoxification reactions. Glutathione reductase (GR)
plays a decisive role as well by regenerating that reduced
GSH from the oxidized form (GSSG or GSH disulfide) to
maintain high intracellular GSH (Rana et al., 2002). While,
catalase catalyzes the decomposition of H2O2 to water and
oxygen, the glutathione peroxidase (GPx) catalyzes the
decrease of hydroperoxides to the detriment of GSH (Flohe,
1989; Ursim et al., 1995). Therefore, these antioxidants pro-
hibit generation of hydroxyl radical and defend the cellular
constituents from oxidative damage (Deepak et al., 2007). In
the present study, levels of GSH, GPx, GRx, and CAT in
the liver of fish injected with AFB1 (group B) decreased
342 M.I. El-Barbarysignificantly when compared to those of the control fish group
(A). These results agree with those of Kozer et al., 2003 who
had reported that the significant decrease in the level of
GSH through AFB1 metabolism might have resulted from
the consumption of GPx and GRx as they have a direct asso-
ciation with GSH. The reduction in these enzymes may be
related to protein production where aflatoxins produce an
extensive number of active metabolites through a biological
conversion and these then bind to DNA and RNA and
decrease protein production (Doerr et al., 1983).
The efficacy of the injection of GSH at the two doses led to
the improvement in the values of all antioxidant enzymes and
in the GSH values in aflatoxicosis groups (E and F) compared
to the AFB1 group (B). The results are in agreement with the
complementary study, El-Barbary and Mohamed (2014), who
reported that glutathione led to a significant increase in total
antioxidant capacity (TAC) values in aflatoxicosis group. Addi-
tionally, the dosage 3 mg/kg BW of GSH (injected IP) showed a
higher significant increase in the TAC values when compared
with other treatments. Also, Otto and Moon, 1995 and Regoli
and Principato, (1995) reported that the defensive role of GSH
against toxicity in aquatic animals was investigated. The mech-
anisms of aflatoxins that induced liver harm showed that glu-
tathione plays a critical role in the detoxification of the toxic
metabolites of aflatoxins and that liver necrosis begins when
the glutathione stores are almost depleted, (Mitchell et al.,
1973; Abdel-Wahhab et al., 2010) clarifying the reduction in
TAC. Shyamal et al. (2010) reported that the cell damage caused
by AFB1 might have reduced by using antioxidants.
In this study, the hepatic gene expression of antioxidant
enzymes such as GPx, and cytochrome P450 was up-regulated
or affected in fish injected with both AFB1 and GSH alone
(groups B and C) when compared with group A. Up-
regulated GPx expression may be responsible for the higher
concentrations of GPx values. In this study, the results of gene
expression correlated with the results of GPx antioxidants
activity values in groups A, C, and E, but they disagreed with
those in group B (Table 3). The induction of CYP1A in the
liver provided a defensive mechanism against the AFB1.
The injection with GSH in aflatoxicosis fish could regulate
GPx gene expressions to the normal levels. Therefore, the GSH
has the potency to relieve AFB1 negative effect on tested hep-
atic antioxidant activity its gene expression.
The induction of antioxidant defense genes suggested a
sturdy increase in cellular ROS creation (van der Oost et al.,
2003). The gene expression of GSH-related enzymes increased
under the condition of oxidative stress in human (Bergelson
et al., 1994; Shi et al., 1994). Furthermore, the relationship
of GPx with AFB1 or its metabolites may explain the reduced
level of TAC (Abdel-Wahhab et al., 2010). The results of gene
expression in this study referred to the CYP1A gene for fish
liver were down-regulated by the GSH that were injected after
aflatoxicosis (group E). That may be because the GSH injec-
tion in fish could reduce the hepatic lesions and protect the
liver from injury by the AFB1 as confirmed by the hepatic
histopathological study and was found to be consistent with
a previous report (El-Barbary and Mohamed, 2014), because
the inhibition of cytochromes (CYP450) may decrease, the dan-
ger of AFB-mediated carcinogenesis. Given the immediate
relationship with the formation of carcinogens, it has been well
accepted that the inhibition of the CYP1 family of enzymes,
is a cancer chemoprevention strategy (Badal et al., 2011). Glu-tathione ability for CYP1A inhibition and antioxidants stimu-
lation for uncovering the pathogenetic mechanism of AFB1
and eliminating its hazard was recorded in the present study.
Conclusion
It could be concluded that AFB1 has significant potency for
increasing plasma creatinine and uric acid values as well as
the reduction of the plasma urea. All these could have been
considered as indicators of the hepatic and kidney dysfunction
and damage. Moreover, it has significant potency for decreas-
ing hepatic GSH, GPx, GRx, and CAT levels in aflatoxicosis
fish. In addition, AFB1 reflected an up-regulation or increase
in the hepatic gene expressions of GPx, and CYP1A. The effi-
cacy of GSH for ameliorating the negative effect of AFB1 was
observed especially at the dose of 3 mg/kg BW, which
improves the values of some blood parameters and hepatic
antioxidants status. It is very interesting to find that GSH
reflected the up regulation and down-regulation in gene expres-
sions of GPx and CYP1A, respectively in fish injected with
both of AFB1 and GSH (group E). The results of the gene
expression gave a splendid indicator of the positive ability of
GSH in the detoxification of aflatoxin in O. niloticus, while
the optimal level of GSH antioxidant for detoxification of afla-
toxin effects may need more studies.Conﬂict of interest
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